UBS Downgrades Impax Laboratories To Sell
April 17, 2015 at 09:05 AM EDT
Analysts at UBS downgraded Impax Laboratories Inc (NASDAQ: IPXL) from Neutral to Sell. Impax Laboratories shares have gained 99.84 ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|